Biliary intraepithelial neoplasia: An international interobserver agreement study and proposal for diagnostic criteria

Modern Pathology

Volumn 20, Issue 6, 2007, Pages 701-709

  Zen, Yoh ^a   Adsay, N Volkan ^b   Bardadin, Krystof ^c   Colombari, Romano ^d   Ferrell, Linda ^e   Haga, Hironori ^f   Hong, Seung Mo ^g   Hytiroglou, Prodromos ^h   Klöppel, Günter ⁱ   Lauwers, Gregory Y ^j   Van Leeuwen, Dirk J ^k   Notohara, Kenji ^l   Oshima, Kiyoko ^m   Quaglia, Alberto ⁿ   Sasaki, Motoko ^a   Sessa, Fausto ^o   Suriawinata, Arief ^k   Tsui, Wilson ^p   Atomi, Yutaka ^q   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^d 'G Fracastoro' City Hospital   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f KYOTO UNIVERSITY HOSPITAL   (Japan)

^g UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^h ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

ⁱ UNIVERSITY OF KIEL   (Germany)

^j HARVARD MEDICAL SCHOOL   (United States)

^k DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^l KURASHIKI CENTRAL HOSPITAL   (Japan)

^m LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

ⁿ KING S COLLEGE HOSPITAL   (United Kingdom)

^o UNIVERSITY OF INSUBRIA   (Italy)

^p Caritas Medical Centre Hong Kong   (Hong Kong)

^q KYORIN UNIVERSITY   (Japan)

more..

Author keywords

Bile duct; Biliary dysplasia; BilIN; Cholangiocarcinoma; Intrahepatic cholangiocarcinoma

Indexed keywords

ARTICLE; ASIA; BILE DUCT STONE; BILE DUCT TUMOR; BILIARY INTRAEPITHELIAL NEOPLASIA; COMMON BILE DUCT STONE; DIAGNOSTIC VALUE; EUROPE; HEPATOBILIARY SYSTEM; HISTOPATHOLOGY; KAPPA STATISTICS; NOMENCLATURE; PATHOLOGIST; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; TUMOR CLASSIFICATION; UNITED STATES;

EID: 34248995330     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800788     Document Type: Article

References (30)

1. Brentnall TA, Bronner MP, Byrd DR, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131:247-255.
2. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-621.
3. Bodner K, Bodner-Adler B,Wierrani F, et al. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res 2003;23:1785-1788.
4. Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995;19:873-886.
5. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399.
6. Bergeron C, Nogales FF, Masseroli M, et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 1999;23:1102-1108.
7. Longnecker DS, Adsay NV, Fernandez-del Castillo C, et al. Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement. Pancreas 2005;31:344-349.
8. Adsay NV, Basturk O, Bonnett M, et al. A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am J Surg Pathol 2005;29:724-733.
9. Nakanuma Y, Harada K, Ishikawa A, et al. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003;10:265-281.
10. Fleming KA, Boberg KM, Glaumann H, et al. Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 2001;34:360-365.
11. Zen Y, Sasaki M, Fujii T, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct - an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 2006;44:350-358.
12. Bu-Ghanim M, Suriawinata A, Killackey M, et al. Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin Liver Dis 2004;24:209-213.
13. Abraham SC, Lee JH, Hruban RH, et al. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol 2003;34:902-910.
14. Kim YS, Myung SJ, Kim SY, et al. Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy 1998;30:763-767.
15. Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001;34:651-658.
16. Kloppel G, Kosmahl M. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? J Hepatol 2006;44:249-250.
17. Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 2006;44:1333-1343.
18. Zen Y, Aishima S, Ajioka Y, et al. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol Int 2005;55:180-188.
19. Nakanuma Y, Sripa B, Vantanasapt V, et al. Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA (eds). World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, 2000, pp 173-180.
20. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-987.
21. Epstein JI. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection. Semin Oncol 1994;21:527-541.
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
23. Kang YK, Kim WH, Jang JJ. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol 2002;33:877-883.
24. Bergquist A, Glaumann H, Stal P, et al. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma. J Intern Med 2001;249:69-75.
25. Lee CS. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma. Eur J Surg Oncol 1997;23:233-237.
26. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.
27. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002;15:1087-1095.
28. Yeh TS, Tseng JH, Chen TC, et al. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology 2005;42:657-664.
29. Shibahara H, Tamada S, Goto M, et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 2004;28:327-338.
30. Zen Y, Fujii T, Itatsu K, et al. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol 2006;19:1243-1254.